v3.26.1
Offerings
Jun. 05, 2026
USD ($)
Offering: 1  
Offering:  
Fee Previously Paid false
Rule 457(o) true
Security Type Equity
Security Class Title Class A CommonStock, $0.001 parvalue per share
Maximum Aggregate Offering Price $ 2,100,000,000.00
Fee Rate 0.01381%
Amount of Registration Fee $ 290,010.00
Offering Note Consists of shares to be issued pursuant to that certain Amended and Restated Controlled Equity OfferingSM Sales Agreement dated June 5, 2026, by and betweenthe Registrant and Cantor Fitzgerald & Co. and Barclays Capital Inc, Clear Street LLC, The Benchmark Company, LLC, StoneX Financial Inc., B. Riley Securities,Inc., Maxim Group LLC and H.C. Wainwright & Co., LLC (the "Sales Agreement"). The proposed maximum aggregate offering price is being used to calculate theregistration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. On September 15, 2025, the registrant filed a prospectus with the Securitiesand Exchange Commission as part of its registration statement on Form S-3ASR (File No. 333-290252) (the "Registration Statement"), relating to the offer and saleof its common stock having an aggregate offering price of up to $450,000,000 pursuant to the terms of the Sales Agreement. The registrant is filing a ProspectusSupplement to increase the aggregate offering price by $2,100,000,000 in the aggregate, excluding the $450,000,000 previously registered. The fee is calculated inaccordance with Rule 456(b) and Rule 457(r) of the Securities Act of 1933, as amended. This "Calculation of Registration Fee" table shall be deemed to update the"Calculation of Registration Fee" table in the registrant's Registration Statement.
Offering: 2  
Offering:  
Fee Previously Paid true
Rule 457(o) true
Security Type Equity
Security Class Title Class A CommonStock, $0.001 parvalue per share
Maximum Aggregate Offering Price $ 450,000,000.00
Amount of Registration Fee $ 68,895.00
Offering Note See note 1. The registrant previously paid a registration fee of $68,895.00 in connection with the filing of the Prospectus Supplement.